Literature DB >> 18631782

Neuropathology of Huntington's disease.

Jean Paul G Vonsattel1, Christian Keller, Maria Del Pilar Amaya.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18631782     DOI： 10.1016/S0072-9752(07)01256-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  26 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.

Authors:  Yi Hong; Lauren J O'Donnell; Peter Savadjiev; Fan Zhang; Demian Wassermann; Ofer Pasternak; Hans Johnson; Jane Paulsen; Jean-Paul Vonsattel; Nikos Makris; Carl F Westin; Yogesh Rathi
Journal:  Hum Brain Mapp       Date:  2018-05-24       Impact factor: 5.038

3.  Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest.

Authors:  Justin J F O'Rourke; William H Adams; Kevin Duff; Joanne Byars; Peg Nopoulos; Jane S Paulsen; Leigh J Beglinger
Journal:  Arch Clin Neuropsychol       Date:  2010-12-08       Impact factor: 2.813

Review 4.  Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.

Authors:  Swarup Mitra; Avijit Banik; Sumit Saurabh; Malabika Maulik; Shailesh N Khatri
Journal:  J Neurosci       Date:  2022-01-13       Impact factor: 6.709

Review 5.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

6.  Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models.

Authors:  Athina Samara; Mariarita Galbiati; Paola Luciani; Cristiana Deledda; Elio Messi; Alessandro Peri; Roberto Maggi
Journal:  J Endocrinol Invest       Date:  2014-06-11       Impact factor: 4.256

7.  AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease.

Authors:  B Connor; Y Sun; D von Hieber; S K Tang; K S Jones; C Maucksch
Journal:  Gene Ther       Date:  2015-12-24       Impact factor: 5.250

8.  The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease.

Authors:  Sarah L Mason; Jiaxiang Zhang; Faye Begeti; Natalie Valle Guzman; Alpar S Lazar; James B Rowe; Roger A Barker; Adam Hampshire
Journal:  Neuropsychologia       Date:  2015-02-17       Impact factor: 3.139

9.  Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

Authors: 
Journal:  Cell Stem Cell       Date:  2012-06-28       Impact factor: 24.633

10.  Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Authors:  Marie Rieux; Melanie Alpaugh; Giacomo Sciacca; Martine Saint-Pierre; Maria Masnata; Hélèna L Denis; Sébastien A Lévesque; Frank Herrmann; Chantal Bazenet; Alexandre P Garneau; Paul Isenring; Ray Truant; Abid Oueslati; Peter V Gould; Anne Ast; Erich E Wanker; Steve Lacroix; Francesca Cicchetti
Journal:  Mol Psychiatry       Date:  2020-06-08       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.